{"id":"https://openalex.org/W1985805365","doi":"https://doi.org/10.2174/1568011053352622","title":"Chemical Aspects of Coumarin Compounds for the Prevention of Hepatocellular Carcinomas","display_name":"Chemical Aspects of Coumarin Compounds for the Prevention of Hepatocellular Carcinomas","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W1985805365","doi":"https://doi.org/10.2174/1568011053352622","mag":"1985805365","pmid":"https://pubmed.ncbi.nlm.nih.gov/15720260"},"language":"en","primary_location":{"id":"doi:10.2174/1568011053352622","doi":"https://doi.org/10.2174/1568011053352622","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568011053352622","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry-Anti-Cancer Agents","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017183121","display_name":"Toshihiro Okamoto","orcid":"https://orcid.org/0000-0002-8777-0467","observed_orcids":["https://orcid.org/0000-0002-8777-0467"]},"institutions":[{"id":"https://openalex.org/I4210093780","display_name":"Nippon Chemiphar (Japan)","ror":"https://ror.org/00kr78d81","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210093780"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshihiro Okamoto","raw_affiliation_strings":["Research Laboratories, Nippon Chemiphar Co., Ltd, Misato, Saitama 341-0005, Japan. t-okamoto@chemiphar.co.jp","Research Laboratories, Nippon Chemiphar Co., Ltd, Misato, Saitama 341-0005, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Nippon Chemiphar Co., Ltd, Misato, Saitama 341-0005, Japan. t-okamoto@chemiphar.co.jp","institution_ids":["https://openalex.org/I4210093780"]},{"raw_affiliation_string":"Research Laboratories, Nippon Chemiphar Co., Ltd, Misato, Saitama 341-0005, Japan","institution_ids":["https://openalex.org/I4210093780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113625949","display_name":"Tadashi Kobayashi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tadashi Kobayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108562424","display_name":"Shin\ufffdichi Yoshida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093780","display_name":"Nippon Chemiphar (Japan)","ror":"https://ror.org/00kr78d81","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210093780"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinichi Yoshida","raw_affiliation_strings":["Research Laboratories, Nippon Chemiphar Co., Ltd, Misato, Saitama 341-0005, Japan.,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Nippon Chemiphar Co., Ltd, Misato, Saitama 341-0005, Japan.,Japan","institution_ids":["https://openalex.org/I4210093780"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.4267,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.95095676,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"5","issue":"1","first_page":"47","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11973","display_name":"Plant chemical constituents analysis","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11973","display_name":"Plant chemical constituents analysis","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.08969999849796295,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12817","display_name":"Pharmacological Effects of Natural Compounds","score":0.032499998807907104,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/coumarins","display_name":"coumarins","score":0.8349999785423279},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma-prevention","display_name":"hepatocellular carcinoma prevention","score":0.9459999799728394},{"id":"https://openalex.org/keywords/osthole","display_name":"osthole","score":0.9319999814033508},{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.796999990940094},{"id":"https://openalex.org/keywords/furocoumarins","display_name":"furocoumarins","score":0.9610000252723694},{"id":"https://openalex.org/keywords/caspase-3-inhibition","display_name":"caspase-3 inhibition","score":0.8840000033378601},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7329999804496765},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.828000009059906},{"id":"https://openalex.org/keywords/concanavalin-a-induced-hepatitis","display_name":"concanavalin A-induced hepatitis","score":0.8939999938011169},{"id":"https://openalex.org/keywords/hepatoprotective-effect","display_name":"hepatoprotection","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2776332754","wikidata":"https://www.wikidata.org/wiki/Q418705","display_name":"Glycyrrhizin","level":2,"score":0.8650171756744385},{"id":"https://openalex.org/C2781338262","wikidata":"https://www.wikidata.org/wiki/Q111812","display_name":"Coumarin","level":2,"score":0.7419198751449585},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.6976728439331055},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6588795185089111},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6322284936904907},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5794726610183716},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.4223713278770447},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39508017897605896},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24144119024276733},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18820154666900635},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.16859516501426697},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000410","descriptor_name":"Alanine Transaminase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000410","descriptor_name":"Alanine Transaminase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003374","descriptor_name":"Coumarins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011564","descriptor_name":"Furocoumarins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019695","descriptor_name":"Glycyrrhizic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1568011053352622","doi":"https://doi.org/10.2174/1568011053352622","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568011053352622","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry-Anti-Cancer Agents","raw_type":"journal-article"},{"id":"pmid:15720260","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15720260","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry. Anti-cancer agents","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2053917544","https://openalex.org/W2086060531","https://openalex.org/W1965747060","https://openalex.org/W2591511724","https://openalex.org/W2913670122","https://openalex.org/W2079501949","https://openalex.org/W2025808503","https://openalex.org/W2156492879","https://openalex.org/W4386376570","https://openalex.org/W2041194439"],"abstract_inverted_index":{"The":[0,67],"normalization":[1],"of":[2,18,58,64,69,134,155,177],"plasma":[3,32,74,94,111,135],"alanine":[4],"aminotransferase":[5],"(ALT)":[6],"has":[7],"been":[8],"proved":[9],"to":[10,72,170],"be":[11,171],"a":[12,28,128,186,191],"strategy":[13],"for":[14,61,173,189],"preventing":[15],"the":[16,62,114,118,153,157,163,174],"development":[17],"hepatocellular":[19],"carcinoma":[20],"(HCC)":[21],"in":[22],"hepatitis":[23,82],"C":[24],"virus":[25],"(HCV)-infection.":[26],"Glycyrrhizin,":[27],"plant":[29],"medicine,":[30],"normalizes":[31],"ALT":[33,75,136],"and":[34,42,83,91,120,137,162],"prevents":[35,194],"HCC.":[36],"However,":[37],"glycyrrhizin":[38],"is":[39,46,51,123,145],"administered":[40],"intravenously":[41],"thereby":[43],"chemical":[44,144,188],"which":[45,193],"effective":[47,119],"on":[48,105,196],"oral":[49,106,197],"administration":[50],"required.":[52],"Coumarin":[53],"compounds":[54,71],"are":[55,98,102],"active":[56],"components":[57],"herbs":[59],"used":[60],"treatment":[63],"various":[65],"diseases.":[66],"ability":[68],"coumarin":[70],"lower":[73,93],"were":[76,168],"examined":[77],"using":[78],"mice":[79,84],"concanavalin":[80],"A-induced":[81],"anti-Fas":[85],"antibody-induced":[86],"hepatitis.":[87],"Furanocoumarins":[88],"pd-Ia,":[89],"pd-II":[90],"pd-III":[92],"ALT,":[95,112],"but":[96,113],"they":[97],"large":[99,149],"molecules":[100],"that":[101,182],"hardly":[103],"absorbed":[104],"administration.":[107,151,198],"Furocoumarin":[108],"effectively":[109],"lowers":[110],"safety":[115],"range":[116],"between":[117],"toxic":[121],"dosages":[122],"narrow.":[124],"In":[125,152],"contrast,":[126],"osthole,":[127,156],"simple":[129],"coumarin,":[130],"causes":[131],"strong":[132],"reduction":[133],"also":[138],"inhibits":[139],"caspase-3":[140],"activation.":[141],"Furthermore,":[142],"this":[143,178],"quite":[146],"safe":[147],"upon":[148],"dose":[150],"structure":[154],"methoxy":[158],"group":[159,165],"at":[160,166],"position-7":[161],"3-methyl-2-butenyl":[164],"position-8":[167],"elucidated":[169],"essential":[172],"beneficial":[175],"effect":[176],"chemical.":[179],"We":[180],"conclude":[181],"osthole":[183],"will":[184],"become":[185],"leading":[187],"synthesizing":[190],"compound":[192],"HCC":[195]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}